{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T19:51:03Z","timestamp":1788205863919,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"the Japan Agency for Medical Research and Development","doi-asserted-by":"crossref","award":["JP20mk0104118"],"award-info":[{"award-number":["JP20mk0104118"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009619","name":"the Japan Agency for Medical Research and Development","doi-asserted-by":"crossref","award":["JP17mk0104044"],"award-info":[{"award-number":["JP17mk0104044"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009619","name":"the Japan Agency for Medical Research and Development","doi-asserted-by":"crossref","award":["JP20mk0104118"],"award-info":[{"award-number":["JP20mk0104118"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Highly sensitive detection of residual undifferentiated pluripotent stem cells is essential for the quality and safety of cell-processed therapeutic products derived from human induced pluripotent stem cells (hiPSCs). We previously reported the generation of an adenovirus (Ad) vector and adeno-associated virus vectors that possess a suicide gene, inducible Caspase 9 (iCasp9), which makes it possible to sensitively detect undifferentiated hiPSCs in cultures of hiPSC-derived cardiomyocytes. In this study, we investigated whether these vectors also allow for detection of undifferentiated hiPSCs in preparations of hiPSC-derived neural progenitor cells (hiPSC-NPCs), which have been expected to treat neurological disorders. To detect undifferentiated hiPSCs, the expression of pluripotent stem cell markers was determined by immunostaining and flow cytometry. Using immortalized NPCs as a model, the Ad vector was identified to be the most efficient among the vectors tested in detecting undifferentiated hiPSCs. Moreover, we found that the Ad vector killed most hiPSC-NPCs in an iCasp9-dependent manner, enabling flow cytometry to detect undifferentiated hiPSCs intermingled at a lower concentration (0.002%) than reported previously (0.1%). These data indicate that the Ad vector selectively eliminates hiPSC-NPCs, thus allowing for sensitive detection of hiPSCs. This cytotoxic viral vector could contribute to ensuring the quality and safety of hiPSCs-NPCs for therapeutic use.<\/jats:p>","DOI":"10.1038\/s41598-021-90928-7","type":"journal-article","created":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T15:32:54Z","timestamp":1622561574000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A selective cytotoxic adenovirus vector for concentration of pluripotent stem cells in human pluripotent stem cell-derived neural progenitor cells"],"prefix":"10.1038","volume":"11","author":[{"given":"Takamasa","family":"Hirai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Kono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rumi","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoko","family":"Matsuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akifumi","family":"Matsuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Koizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Utoguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Mizuguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoji","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,1]]},"reference":[{"key":"90928_CR1","doi-asserted-by":"publisher","first-page":"16825","DOI":"10.1073\/pnas.1108077108","volume":"108","author":"S Nori","year":"2011","unstructured":"Nori, S. et al. Grafted human-induced pluripotent stem-cell\u2013derived neurospheres promote motor functional recovery after spinal cord injury in mice. Proc. Natl. Acad. Sci. U.S.A. 108, 16825\u201316830 (2011).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"90928_CR2","doi-asserted-by":"publisher","first-page":"e52787","DOI":"10.1371\/journal.pone.0052787","volume":"7","author":"Y Kobayashi","year":"2012","unstructured":"Kobayashi, Y. et al. Pre-evaluated safe human iPSC-derived neural stem cells promote functional recovery after spinal cord injury in common marmoset without tumorigenicity. PLoS ONE 7, e52787 (2012).","journal-title":"PLoS ONE"},{"key":"90928_CR3","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1002\/stem.1104","volume":"30","author":"K Oki","year":"2012","unstructured":"Oki, K. et al. Human-induced pluripotent stem cells form functional neurons and improve recovery after grafting in stroke-damaged brain. Stem Cells 30, 1120\u20131133 (2012).","journal-title":"Stem Cells"},{"key":"90928_CR4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/stem.2926","volume":"37","author":"O Tsuji","year":"2019","unstructured":"Tsuji, O. et al. Concise review: Laying the groundwork for a first in-human study of an induced pluripotent stem cell-based intervention for spinal cord injury. Stem Cells 37, 6\u201313 (2019).","journal-title":"Stem Cells"},{"key":"90928_CR5","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.stemcr.2015.01.006","volume":"4","author":"S Nori","year":"2015","unstructured":"Nori, S. et al. Long-term safety issues of iPSC-based cell therapy in a spinal cord injury model: oncogenic transformation with epithelial\u2013mesenchymal transition. Stem Cell Rep. 4, 360\u2013373 (2015).","journal-title":"Stem Cell Rep."},{"key":"90928_CR6","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.stemcr.2016.08.015","volume":"7","author":"T Okubo","year":"2016","unstructured":"Okubo, T. et al. Pretreatment with a gamma-secretase inhibitor prevents tumor-like overgrowth in human iPSC-derived transplants for spinal cord injury. Stem Cell Rep. 7, 649\u2013663 (2016).","journal-title":"Stem Cell Rep."},{"key":"90928_CR7","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.stemcr.2017.02.003","volume":"8","author":"G Itakura","year":"2017","unstructured":"Itakura, G. et al. Fail-safe system against potential tumorigenicity after transplantation of iPSC derivatives. Stem Cell Rep. 8, 673\u2013684 (2017).","journal-title":"Stem Cell Rep."},{"key":"90928_CR8","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/nrc3034","volume":"11","author":"U Ben-David","year":"2011","unstructured":"Ben-David, U. & Benvenisty, N. The tumorigenicity of human embryonic and induced pluripotent stem cells. Nat. Rev. Cancer 11, 268\u2013277 (2011).","journal-title":"Nat. Rev. Cancer"},{"key":"90928_CR9","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.jcyt.2019.10.001","volume":"21","author":"Y Sato","year":"2019","unstructured":"Sato, Y. et al. Tumorigenicity assessment of cell therapy products: The need for global consensus and points to consider. Cytotherapy 21, 1095\u20131111 (2019).","journal-title":"Cytotherapy"},{"key":"90928_CR10","doi-asserted-by":"publisher","first-page":"e37342","DOI":"10.1371\/journal.pone.0037342","volume":"7","author":"T Kuroda","year":"2012","unstructured":"Kuroda, T. et al. Highly sensitive in vitro methods for detection of residual undifferentiated cells in retinal pigment epithelial cells derived from human iPS cells. PLoS ONE 7, e37342 (2012).","journal-title":"PLoS ONE"},{"key":"90928_CR11","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.reth.2015.08.001","volume":"2","author":"T Kuroda","year":"2015","unstructured":"Kuroda, T. et al. Highly sensitive droplet digital PCR method for detection of residual undifferentiated cells in cardiomyocytes derived from human pluripotent stem cells. Regen. Ther. 2, 17\u201323 (2015).","journal-title":"Regen. Ther."},{"key":"90928_CR12","doi-asserted-by":"publisher","first-page":"e110496","DOI":"10.1371\/journal.pone.0110496","volume":"9","author":"K Tano","year":"2014","unstructured":"Tano, K. et al. A novel in vitro method for detecting undifferentiated human pluripotent stem cells as impurities in cell therapy products using a highly efficient culture system. PLoS ONE 9, e110496 (2014).","journal-title":"PLoS ONE"},{"key":"90928_CR13","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.reth.2019.05.006","volume":"11","author":"N Nagoshi","year":"2019","unstructured":"Nagoshi, N., Tsuji, O., Nakamura, M. & Okano, H. Cell therapy for spinal cord injury using induced pluripotent stem cells. Regen. Ther. 11, 75\u201380 (2019).","journal-title":"Regen. Ther."},{"key":"90928_CR14","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1002\/stem.108","volume":"27","author":"K Tashiro","year":"2009","unstructured":"Tashiro, K. et al. Efficient adipocyte and osteoblast differentiation from mouse induced pluripotent stem cells by adenoviral transduction. Stem Cells 27, 1802\u20131811 (2009).","journal-title":"Stem Cells"},{"key":"90928_CR15","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1089\/cell.2010.0023","volume":"12","author":"K Tashiro","year":"2010","unstructured":"Tashiro, K. et al. Adenovirus vector-mediated efficient transduction into human embryonic and induced pluripotent stem cells. Cell Reprogram. 12, 501\u2013507 (2010).","journal-title":"Cell Reprogram."},{"key":"90928_CR16","doi-asserted-by":"publisher","first-page":"3630","DOI":"10.1038\/s41598-018-36848-5","volume":"9","author":"K Kono","year":"2019","unstructured":"Kono, K. et al. Development of selective cytotoxic viral vectors for concentration of undifferentiated cells in cardiomyocytes derived from human induced pluripotent stem cells. Sci. Rep. 9, 3630 (2019).","journal-title":"Sci. Rep."},{"key":"90928_CR17","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.bbrc.2013.01.025","volume":"431","author":"Y Onuma","year":"2013","unstructured":"Onuma, Y. et al. rBC2LCN, a new probe for live cell imaging of human pluripotent stem cells. Biochem. Biophys. Res. Commun. 431, 524\u2013529 (2013).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"90928_CR18","doi-asserted-by":"publisher","first-page":"7909","DOI":"10.1128\/JVI.72.10.7909-7915.1998","volume":"72","author":"PW Roelvink","year":"1998","unstructured":"Roelvink, P. W. et al. The coxsackievirus-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E, and F. J. Virol. 72, 7909\u20137915 (1998).","journal-title":"J. Virol."},{"key":"90928_CR19","doi-asserted-by":"publisher","first-page":"3352","DOI":"10.1073\/pnas.94.7.3352","volume":"94","author":"RP Tomko","year":"1997","unstructured":"Tomko, R. P., Xu, R. & Philipson, L. HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc. Natl. Acad. Sci. U.S.A. 94, 3352\u20133356 (1997).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"90928_CR20","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1006\/mthe.2001.0512","volume":"5","author":"SM Hughes","year":"2002","unstructured":"Hughes, S. M., Moussavi-Harami, F., Sauter, S. L. & Davidson, B. L. Viral-mediated gene transfer to mouse primary neural progenitor cells. Mol. Ther. 5, 16\u201324 (2002).","journal-title":"Mol. Ther."},{"key":"90928_CR21","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1089\/153623003321512166","volume":"5","author":"JR Smith-Arica","year":"2003","unstructured":"Smith-Arica, J. R. et al. Infection efficiency of human and mouse embryonic stem cells using adenoviral and adeno-associated viral vectors. Cloning Stem Cells 5, 51\u201362 (2003).","journal-title":"Cloning Stem Cells"},{"key":"90928_CR22","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/1743-422X-10-74","volume":"10","author":"BL Ellis","year":"2013","unstructured":"Ellis, B. L. et al. A survey of ex vivo\/in vitro transduction efficiency of mammalian primary cells and cell lines with nine natural adeno-associated virus (AAV1-9) and one engineered adeno-associated virus serotype. Virol. J. 10, 74 (2013).","journal-title":"Virol. J."},{"key":"90928_CR23","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1471-2202-8-36","volume":"8","author":"R Donato","year":"2007","unstructured":"Donato, R. et al. Differential development of neuronal physiological responsiveness in two human neural stem cell lines. BMC Neurosci. 8, 36 (2007).","journal-title":"BMC Neurosci."},{"key":"90928_CR24","doi-asserted-by":"publisher","first-page":"515","DOI":"10.2478\/s11658-011-0021-0","volume":"16","author":"O Mazemondet","year":"2011","unstructured":"Mazemondet, O. et al. Quantitative and kinetic profile of Wnt\/\u03b2-catenin signaling components during human neural progenitor cell differentiation. Cell. Mol. Biol. Lett. 16, 515\u2013538 (2011).","journal-title":"Cell. Mol. Biol. Lett."},{"key":"90928_CR25","doi-asserted-by":"publisher","first-page":"18979","DOI":"10.1074\/jbc.M201257200","volume":"277","author":"R Aikawa","year":"2002","unstructured":"Aikawa, R., Huggins, G. S. & Snyder, R. O. Cardiomyocyte-specific gene expression following recombinant adeno-associated viral vector transduction. J. Biol. Chem. 277, 18979\u201318985 (2002).","journal-title":"J. Biol. Chem."},{"key":"90928_CR26","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/0092-8674(82)90274-4","volume":"30","author":"LH Shevinsky","year":"1982","unstructured":"Shevinsky, L. H., Knowles, B. B., Damjanov, I. & Solter, D. Monoclonal antibody to murine embryos defines a stage-specific embryonic antigen expressed on mouse embryos and human teratocarcinoma cells. Cell 30, 697\u2013705 (1982).","journal-title":"Cell"},{"key":"90928_CR27","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1002\/j.1460-2075.1983.tb01746.x","volume":"2","author":"R Kannagi","year":"1983","unstructured":"Kannagi, R. et al. Stage-specific embryonic antigens (SSEA-3 and -4) are epitopes of a unique globoseries ganglioside isolated from human teratocarcinoma cells. EMBO J. 2, 2355\u20132361 (1983).","journal-title":"EMBO J."},{"key":"90928_CR28","doi-asserted-by":"publisher","first-page":"8934","DOI":"10.1016\/S0021-9258(18)32147-1","volume":"258","author":"R Kannagi","year":"1983","unstructured":"Kannagi, R. et al. New globoseries glycosphingolipids in human teratocarcinoma reactive with the monoclonal antibody directed to a developmentally regulated antigen, stage-specific embryonic antigen 3. J. Biol. Chem. 258, 8934\u20138942 (1983).","journal-title":"J. Biol. Chem."},{"key":"90928_CR29","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1634\/stemcells.2005-0597","volume":"25","author":"WM Schopperle","year":"2007","unstructured":"Schopperle, W. M. & DeWolf, W. C. The TRA-1-60 and TRA-1-81 human pluripotent stem cell markers are expressed on podocalyxin in embryonal carcinoma. Stem Cells 25, 723\u2013730 (2007).","journal-title":"Stem Cells"},{"key":"90928_CR30","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1093\/glycob\/cwq209","volume":"21","author":"S Natunen","year":"2011","unstructured":"Natunen, S. et al. The binding specificity of the marker antibodies Tra-1-60 and Tra-1-81 reveals a novel pluripotency-associated type 1 lactosamine epitope. Glycobiology 21, 1125\u20131130 (2011).","journal-title":"Glycobiology"},{"key":"90928_CR31","doi-asserted-by":"publisher","first-page":"20345","DOI":"10.1074\/jbc.M111.231274","volume":"286","author":"H Tateno","year":"2011","unstructured":"Tateno, H. et al. Glycome diagnosis of human induced pluripotent stem cells using lectin microarray. J. Biol. Chem. 286, 20345\u201320353 (2011).","journal-title":"J. Biol. Chem."},{"key":"90928_CR32","doi-asserted-by":"crossref","unstructured":"Watanabe, T. et al. Multisite studies for validation and improvement of a highly efficient culture assay for detection of undifferentiated human pluripotent stem cells intermingled in cell therapy products. Cytotherapy 23, 176\u2013183 (2021).","DOI":"10.1016\/j.jcyt.2020.07.009"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-90928-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-90928-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-90928-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T09:04:57Z","timestamp":1670058297000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-90928-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,1]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["90928"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-90928-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,1]]},"assertion":[{"value":"18 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11407"}}